NFKB1 and amyotrophic lateral sclerosis: In ALS, two independent studies reported that inhibition of the NF-κB pathway in reactive astrocytes does not influence disease phenotype in SOD1G93A mice (Crosio et al., 2011; Frakes et al., 2014).